Literature DB >> 12512185

Aspergillosis. Pathogenesis, clinical manifestations, and therapy.

Kieren A Marr1, Thomas Patterson, David Denning.   

Abstract

Diseases caused by Aspergillus species are increasing in importance, especially among immunocompromised hosts. Clinical manifestations are variable, ranging from allergic to invasive disease, largely depending on the status of the host's immune system. This article focuses on the pathogenesis and clinical manifestations of diseases caused by Aspergillus species, with more detailed discussion on therapy of the most morbid manifestation, invasive aspergillosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512185     DOI: 10.1016/s0891-5520(02)00035-1

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  82 in total

1.  Larvicidal activity of isolated compound 5-(2,4-dimethylbenzyl) pyrrolidin-2-one from marine Streptomyces VITSVK5 sp. against Rhipicephalus (Boophilus) microplus, Anopheles stephensi, and Culex tritaeniorhynchus.

Authors:  Kumar Saurav; Govindasamy Rajakumar; Krishnan Kannabiran; Abdul Abdul Rahuman; Kanayairam Velayutham; Gandhi Elango; Chinnaperumal Kamaraj; Abdul Abduz Zahir
Journal:  Parasitol Res       Date:  2011-10-19       Impact factor: 2.289

2.  The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus.

Authors:  Haiyan Li; Bridget M Barker; Nora Grahl; Srisombat Puttikamonkul; Jeremey D Bell; Kelly D Craven; Robert A Cramer
Journal:  Eukaryot Cell       Date:  2010-12-23

3.  LaeA, a regulator of morphogenetic fungal virulence factors.

Authors:  Jin Woo Bok; S Arunmozhi Balajee; Kieren A Marr; David Andes; Kristian Fog Nielsen; Jens C Frisvad; Nancy P Keller
Journal:  Eukaryot Cell       Date:  2005-09

4.  Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Joseph Meletiadis; Rafal Al-Saigh; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides; Loukia Zerva
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

5.  Aspergillosis of biliary tract after liver transplantation: a case report.

Authors:  Chen Yuchong; Zhu Dingheng; Yuan Zhizhong; Yu Hongyu; He Jing; Chen Jianghan
Journal:  Mycopathologia       Date:  2010-03-24       Impact factor: 2.574

6.  Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing.

Authors:  Jason P Trama; Eli Mordechai; Martin E Adelson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

7.  Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis.

Authors:  Viviane Balloy; Michel Huerre; Jean-Paul Latgé; Michel Chignard
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.

Authors:  Mojtaba Taghizadeh-Armaki; Mohammad Taghi Hedayati; Saham Ansari; Saeed Mahdavi Omran; Sasan Saber; Haleh Rafati; Jan Zoll; Henrich A van der Lee; Willem J G Melchers; Paul E Verweij; Seyedmojtaba Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 9.  [Therapy of severe fungal infections].

Authors:  M Battegay; U Flückiger
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

10.  Role of phosphatidylinositol-3-kinase (PI3K), extracellular signal-regulated kinase (ERK) and nuclear transcription factor kappa beta (NF-k beta) on neutrophil phagocytic process of Candida albicans.

Authors:  E Giraldo; L Martin-Cordero; M D Hinchado; J J Garcia; E Ortega
Journal:  Mol Cell Biochem       Date:  2009-07-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.